Anaemia is associated with increased perinatal mortality, increased child morbidity and mortality, behavioural changes and impaired mental development, decreased work performance, increased susceptibility to lead poisoning, and impaired immune competence. Iron-deficiency anaemia is an intractable problem, as indicated by the goal set by world leaders of reducing nutritional anaemia to one-third of 1990 levels by the year 2000, compared with the goals of virtually eliminating deficiencies of vitamin A and of iodine during the same period. To a large extent, this is because intake is less associated with status for iron than for iodine and vitamin A. The demand for iron varies throughout the life cycle, and the bioavailability of iron varies over a wide range because of a number of factors, such as the species of iron compound, the molecular linkage, the amount of nutrient consumed in a meal, the matrix in which the nutrient is incorporated, the absorption modifiers, the nutrient status of the host, genetic factors, other host-related factors, and interactions among factors.
Introduction
Iron deficiency is a problem in both developed and developing countries, affecting about 1,000 million people worldwide, including 370 million women of child-bearing age. In developed countries, it is primarily a problem of these women and young children, and usually occurs as an isolated nutritional problem. In developing countries, such as Indonesia, it extends to older children and usually occurs together with deficiencies of other nutrients [1] .
Because of the magnitude of the problem and its serious consequences, a series of meetings has been held in recent years, beginning with the World Summit for Children in New York in 1990, followed in 1991 by the conference on Ending Hidden Hunger in Montreal, and culminating in 1992 with the International Conference on Nutrition in Rome. These led to declarations by heads of state of most countries of the world committing their countries to reducing iron-deficiency anaemia in women of childbearing age to one-third of 1992 levels by the year 2000 [2] . Such a limited goal, compared with the goals of virtually eliminating deficiencies of vitamin A and of iodine, is an admission of the intractability of the problem of iron-deficiency anaemia.
Consequences of iron deficiency
As shown in a series of studies in Indonesia and other countries, attention, learning achievement, and mental development are affected by anaemia in children [3, 4] , and these effects can be reversed by iron supplementation when the children are under the age of 10 years but not older [5] . In addition, in Indonesia, iron-deficient rubber plantation labourers were less productive than workers with normal haemoglobin concentrations, and iron supplementation improved their performance [6] . Work performance was particularly impaired when the haemoglobin concentration fell below 100 g/L, which is 20 to 40 g/L below the lower limit of normal for adults. From the point of view of a government, impairments of mental development and work performance are good reasons to combat iron-deficiency anaemia.
From the point of view of the individual, other aspects of iron deficiency also assume importance. Decreased resistance to infection is due to impairment of both specific and non-specific defense mechanisms. Impairment of specific immunity is particularly noticeable with cell-mediated immunity, whereas oxygen-dependent killing rather than phagocytosis is the most important aspect of non-specific immunity that is affected. An impaired capacity to maintain body temperature in a cold environment is characteristic of iron-deficiency anaemia [7] . Another consequence is lead poisoning, the risk of which is increased in anaemic children, particularly when they are young [8] . Reducing the lead in petrol rather than improving iron status may be the most effective way of approaching this problem. Finally, iron-deficiency anaemia during pregnancy has very serious consequences, leading to increased risk of perinatal mortality and to increased infant mortality [2] .
Measuring prevalence of iron deficiency and of iron-deficiency anaemia
In a research environment, a battery of haematological and biochemical measurements can be made, such as haemoglobin, haematocrit, mean corpuscular volume, serum transferrin, serum iron (and transferrin saturation), serum ferritin, free erythrocyte protoporphyrin, and transferrin receptor. However, these methods are generally inappropriate in an operational environment where haemoglobin distribution curves can be used [9] . A shift to the left, compared with a population without anaemia, is indicative of anaemia. In areas where the anaemia is due to iron deficiency, such a shift is seen only in children and women, not in men. If the distribution in men is also shifted to the left, it indicates anaemia due to infection or infestation such as from malaria or from hookworm.
Methods of combating iron deficiency
Several possible approaches to combating iron-deficiency anaemia exist. The most obvious is supplementation with iron preparations. Until the present time, this has been the principal method used in developing countries. Programmes often were ineffective, however, because the target group was not reached, compliance was poor, and the preparations used sometimes had low bioavailability of iron [10] . Compliance will almost certainly be increased when daily schedules are replaced by weekly schedules [10] and when the preparations used contain iron in a more bioavailable form.
Food fortification has proved effective in reducing iron-deficiency anaemia, particularly in the United States. The reason for this is not only that American industry is able to manufacture and market iron-fortified products, but also that legislation and accompanying regulations allow fortification to be maintained. By contrast, in many countries in Europe, legislation and regulations are very restrictive with respect to food fortification.
The technology for fortifying foods with iron has improved much in recent years. Problems of offflavour have been overcome, and compounds with higher iron bioavailability, such as ferrous fumarate, have been introduced. However, increasing bioavailability by removing inhibitors of iron absorption through fermentation and use of phytases can be effective and, combined with enhancing bioavailability through increased consumption of enhancers such as ascorbic acid, may make fortification unnecessary. This is an area in which much more applied and operations research applicable to developing countries has to be done. Iron supply can be increased not only by choosing animal products rich in haem iron but also by choosing traditional iron-rich plant foods. Recently, much interest has been expressed in increasing the total amount of iron and the proportion per content that is bioavailable through breeding and genetic engineering [11] . It remains to be seen what can be achieved by these means.
Any programme to control iron deficiency has to take into account other nutrients, infection, and other factors. Folic acid and vitamin B12 are required for the synthesis of the haem molecule in haemoglobin. Supplementation with vitamin A increases haemoglobin levels in anaemic women with marginal or just adequate vitamin A levels [12] , probably by an effect on the uptake of iron by the erythropoietic system [13] . Riboflavin supplementation increases haemoglobin levels in riboflavin-deficient subjects [14] , probably predominantly by an accelerated rate of epithelial turnover in the small intestine [15] .
It is well known that hookworm and malaria are important aetiological factors in nutritional anaemia, so greater efforts must be taken not only to increase iron intake but also to reduce iron losses from these causes. In addition, it should be noted that oral contraception reduces menstrual blood loss and intrauterine contraceptive devices generally increase iron loss.
In addition to choosing an approach or series of approaches to controlling iron-deficiency anaemia, the public has to be mobilized [16] . This involves advocacy to those responsible for making decisions about programmes to control iron deficiency. It is also essential to educate the public to change food habits to eat more haem iron-containing foods and to eat non-haeme iron foods that enhance iron bioavailability. The public must be made aware of the value of consuming foods that enhance non-haem iron bioavailability with meals (orange juice), and of not consuming those that inhibit non-haem iron bioavailability (tea).
Bioavailability
Iron bioavailability has been addressed by research workers [17] but has not yet received the attention it deserves by those responsible for programmes controlling iron deficiency. It is the proportion of iron ingested that becomes available to the body for metabolie processes, and most work in the area is still guided by the algorithm for iron bioavailability developed by Monsen and colleagues in 1978 [18] . In this algorithm, the absorption of haem iron is assumed to be 15% in men and 23% to 35% in women, depending on iron stores. For non-haem iron, absorption depends on bioavailability (low, medium, high) estimated in general terms from the phytate, haem, and ascorbic acid contents of a meal. Thus, for men the range is 2% to 4%, and for women it is 3% to 20%, also depending on iron stores as follows: 5% to 20% with low iron stores (0 mg iron); 4% to 12% with medium iron stores (250 mg iron); 3% to 8% with high iron stores (500 mg iron). However, it seems to be time to consider more factors when calculating bioavailability. Therefore, we propose an approach that focuses on the following [19] species of iron compound, molecular linkage, amount of nutrient consumed in a meal, matrix in which the nutrient is incorporated, absorption modifiers, nutrient status of the host, genetic factors, other host-related factors, and interactions.
Species of iron
Iron is probably absorbed only in the ferrous form, so elemental iron has to be oxidized and ferric iron reduced to ferrous iron before absorption. Thus, it is important to know the proportion of the various atomic species in a food.
Molecular linkage
Haem iron is absorbed to a much greater extent than non-haem iron. In iron-deficient persons, the absorption of haem iron is about 35% and the absorption of nonhaem iron is about 25%, when enhancers are abundant (see below). The corresponding figures in an iron-replete subject are 15% and 2%. Enhancers and inhibitors exert their effect only on the absorption of non-haem iron, although the inhibition of absorption of non-haem iron by dietary calcium is an exception. Ferrous iron in the form of fumarate is absorbed much better than ferrous sulphate.
An additional problem with elemental iron is the particle size, as fine particles, such as iron reductum produced by reducing ferrous iron, are absorbed much better than coarser particles.
Amount of iron in the diet
Iron absorption is reduced to some extent at increased levels of iron intake. More important, perhaps, is the effect of high intake that down-regulates the capacity of the intestinal epithelium to absorb iron subsequently.
Food matrix
Matrix effects are probably more pronounced for nonhaem than for haem iron. This is based on experience with the low bioavailability of plant carotenoids [20] .
Absorption modifiers
A number of compounds in the diet affect the bioavailability of iron. Ascorbic acid in the diet enhances the absorption of non-haem iron, probably by reducing ferric iron to ferrous iron, the form in which iron is probably absorbed from the intestine. Dietary ascorbic acid probably also prevents the precipitation in the intestinal lumen of ferric complexes such as ferric hydroxide. The effect of ascorbic acid on non-haem iron absorption is marked and strongly dose related, especially for the first 50 mg of ascorbic acid in a meal.
A second factor is meat, which stimulates non-haem iron absorption. This is due in part to the haem in the diet, but is possibly also a result of other dietary factors such as individual amino acids. Acidic foods also stimulate iron absorption, which probably explains the stimulatory effects of fermented foods such as sauerkraut, which is prepared from cabbage, and enjera, which is prepared from the cereal teff in Ethiopia.
Phytate (inositol phosphate) is perhaps the most important dietary constituent inhibiting non-haem iron absorption, but fortunately its effect can be counteracted by increasing ascorbic acid intake. It is interesting to note that inositol with up to three phosphate groups stimulates iron absorption, whereas inositol with four to six phosphate groups inhibits absorption. Another powerful inhibitor of absorption is the group of plant phenolic compounds such as those from tea and coffee, and their effect is also reversed by dietary ascorbic acid.
Other minerals can influence the absorption of iron. As mentioned, calcium inhibits the absorption of not only non-haem but also haem iron. This inhibition is not reversed by ascorbic acid. Magnesium acts in the same way as calcium and to the same extent. However, interference from dietary magnesium is less because the intake is less than that of calcium. Manganese, but not zinc, in the diet reduces iron absorption.
Nutrient status of the host
Iron status has a marked effect on absorption of iron, especially non-haem iron. It is affected not only by intake and absorption but also by iron utilization and losses. Utilization varies throughout the life cycle, and losses are increased by menstruation, haemorrhage, blood donation, the action of parasites such as hookworm, and malaria.
Genetic constitution of the host
Iron overload is a genetic condition in which people absorb large amounts of iron that is not subject to negative feedback. The problem can be overcome by introducing a programme of screening for iron nutriture abnormalities, with the aim of detecting individuals with anaemia and those with iron overload.
Other host-related factors
Intestinal parasites such as Giardia lamblia and Ascaris lumbricoides possibly reduce the absorption of iron. Such a negative effect on bioavailability is quite separate from that of hookworm in increasing iron loss from the body.
Interactions among the above
All of these factors should be taken into account when designing a programme to control iron-deficiency anaemia. When trying to evaluate the magnitude of the effects of these factors, not only should the effects be quantified independently of one another, but the interaction among the factors should also be measured.
It is hoped that in the future we will be able to evaluate the impact of all these variables on iron absorption. It will then be possible to come up with mathematical values to fit our proposed approach, which could replace the algorithm of Monsen et al. that has served us well for nearly 20 years [18] . Particular attention should be paid to absorption modifiers and to parasites.
Conclusion
Iron-deficiency anaemia is a serious problem because of its impact on individuals and because of the large number of individuals it affects. Much work has been and is being done to control the problem, but programmes should pay more attention to increasing iron bioavailability rather than iron intake.
